Nektar Therapeutics (NKTR) vs Syndax Pharmaceuticals, Inc. (SNDX)
- Nektar Therapeutics NKTR 35.78 −5.14%
- Syndax Pharmaceuticals, Inc. SNDX 12.88 −5.64%
Nektar Therapeutics and Syndax Pharmaceuticals, Inc. are both Biotechnology companies. Nektar Therapeutics and Syndax Pharmaceuticals, Inc. are of similar size ($1.3B and $1.2B). Syndax Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 222.3% against −27.2%. Syndax Pharmaceuticals, Inc. has the higher net margin (−87.6% vs −287.8%) and the lower return on invested capital (−247.9% vs −40.2%). Across the 18 metrics below, Syndax Pharmaceuticals, Inc. leads on 10 and Nektar Therapeutics on 8.
Valuation
Profitability
| Metric | NKTR | SNDX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 95.78% | 65.16% |
| Operating margin | (257.80%) | (77.05%) | 0.00% |
| Net margin | (287.84%) | (87.60%) | 0.00% |
| Free cash flow margin | (428.72%) | (87.64%) | 0.00% |
| Return on equity | (35.75%) | (255.93%) | (56.36%) |
| Return on assets | (24.12%) | (33.97%) | (48.04%) |
| Return on invested capital | (40.20%) | (247.93%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack